top of page

NICE says ‘yes ‘ to bosutinib for chronic myeloid leukaemia

The National Institute for Health and Care Excellence (NICE) has recommended Pfizer’s Bosulif (bosutinib) for treating some people with chronic myeloid leukaemia.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page